283 related articles for article (PubMed ID: 25321647)
1. Magnesium sulfate exposure and neonatal intensive care unit admission at term.
Girsen AI; Greenberg MB; El-Sayed YY; Lee H; Carvalho B; Lyell DJ
J Perinatol; 2015 Mar; 35(3):181-5. PubMed ID: 25321647
[TBL] [Abstract][Full Text] [Related]
2. The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study.
Riaz M; Porat R; Brodsky NL; Hurt H
J Perinatol; 1998; 18(6 Pt 1):449-54. PubMed ID: 9848759
[TBL] [Abstract][Full Text] [Related]
3. Effect of magnesium sulfate exposure on term neonates.
Greenberg MB; Penn AA; Whitaker KR; Kogut EA; El-Sayed YY; Caughey AB; Lyell DJ
J Perinatol; 2013 Mar; 33(3):188-93. PubMed ID: 22836873
[TBL] [Abstract][Full Text] [Related]
4. Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks' gestation.
Jung EJ; Byun JM; Kim YN; Lee KB; Sung MS; Kim KT; Shin JB; Jeong DH
J Matern Fetal Neonatal Med; 2018 Jun; 31(11):1431-1441. PubMed ID: 28391733
[TBL] [Abstract][Full Text] [Related]
5. Neonatal magnesium levels are safe after maternal MgSO
Dehaene I; Van Steenstraeten T; De Coen K; De Buyser S; Decruyenaere J; Smets K; Roelens K
Eur J Pediatr; 2022 Aug; 181(8):2971-2980. PubMed ID: 35595861
[TBL] [Abstract][Full Text] [Related]
6. Term Neonatal Outcomes after Maternal Magnesium Sulfate Treatment for Seizure Prophylaxis.
Chornock R; Trieu E; Kawakita T; Dean B; Overcash R
Am J Perinatol; 2023 Jul; 40(9):923-928. PubMed ID: 36634701
[TBL] [Abstract][Full Text] [Related]
7. Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes.
Faucett AM; Metz TD; DeWitt PE; Gibbs RS
Am J Obstet Gynecol; 2016 Feb; 214(2):287.e1-287.e5. PubMed ID: 26435047
[TBL] [Abstract][Full Text] [Related]
8. Effect of magnesium sulfate treatment on neonatal bone abnormalities.
Matsuda Y; Maeda Y; Ito M; Sakamoto H; Masaoka N; Takada M; Sato K
Gynecol Obstet Invest; 1997; 44(2):82-8. PubMed ID: 9286718
[TBL] [Abstract][Full Text] [Related]
9. Maternal and newborn outcomes with elective induction of labor at term.
Souter V; Painter I; Sitcov K; Caughey AB
Am J Obstet Gynecol; 2019 Mar; 220(3):273.e1-273.e11. PubMed ID: 30716284
[TBL] [Abstract][Full Text] [Related]
10. Maternal, fetal, and neonatal outcomes among different types of hypertensive disorders associating pregnancy needing intensive care management.
Maged AM; Elsherief A; Hassan H; Salaheldin D; Omran KA; Almohamady M; Dahab S; Fahmy R; AbdelHak A; Shoab AY; Lotfy R; Lasheen YS; Nabil H; Elbaradie SMY
J Matern Fetal Neonatal Med; 2020 Jan; 33(2):314-321. PubMed ID: 29914278
[No Abstract] [Full Text] [Related]
11. Maternal and Neonatal Outcomes of Induction of Labor Compared with Planned Cesarean Delivery in Women with Preeclampsia at 34 Weeks' Gestation or Longer.
Kawakita T; Bowers K
Am J Perinatol; 2018 Jan; 35(1):95-102. PubMed ID: 28838008
[TBL] [Abstract][Full Text] [Related]
12. [Magnesium sulfate in obstetrics: current data].
Azria E; Tsatsaris V; Goffinet F; Kayem G; Mignon A; Cabrol D
J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 1):510-7. PubMed ID: 15567967
[TBL] [Abstract][Full Text] [Related]
13. Unexpected term NICU admissions: a marker of obstetrical care quality?
Clapp MA; James KE; Bates SV; Kaimal AJ
Am J Obstet Gynecol; 2019 Apr; 220(4):395.e1-395.e12. PubMed ID: 30786256
[TBL] [Abstract][Full Text] [Related]
14. The impact of the definition of preeclampsia on disease diagnosis and outcomes: a retrospective cohort study.
Reddy M; Fenn S; Rolnik DL; Mol BW; da Silva Costa F; Wallace EM; Palmer KR
Am J Obstet Gynecol; 2021 Feb; 224(2):217.e1-217.e11. PubMed ID: 32795430
[TBL] [Abstract][Full Text] [Related]
15. Use of magnesium sulfate before 32 weeks of gestation: a European population-based cohort study.
Wolf HT; Huusom L; Weber T; Piedvache A; Schmidt S; Norman M; Zeitlin J;
BMJ Open; 2017 Jan; 7(1):e013952. PubMed ID: 28132012
[TBL] [Abstract][Full Text] [Related]
16. The impact of cesarean section on neonatal outcomes at a university-based tertiary hospital in Jordan.
Khasawneh W; Obeidat N; Yusef D; Alsulaiman JW
BMC Pregnancy Childbirth; 2020 Jun; 20(1):335. PubMed ID: 32487165
[TBL] [Abstract][Full Text] [Related]
17. Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates.
Havranek T; Ashmeade TL; Afanador M; Carver JD
Neonatology; 2011; 100(1):44-9. PubMed ID: 21212694
[TBL] [Abstract][Full Text] [Related]
18. An audit of the use of magnesium sulphate in severe pre-eclampsia and eclampsia.
Singh J; O'Donovan M; Coulter-Smith SD; Geary M
J Obstet Gynaecol; 2005 Jan; 25(1):15-7. PubMed ID: 16147685
[TBL] [Abstract][Full Text] [Related]
19. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
[TBL] [Abstract][Full Text] [Related]
20. Maternal and neonatal outcomes associated with induction of labor after one previous cesarean delivery: A French retrospective study.
Vecchioli E; Cordier AG; Chantry A; Benachi A; Monier I
PLoS One; 2020; 15(8):e0237132. PubMed ID: 32764773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
